What it isTriazole antifungal; onychomycosis, histoplasmosis and blastomycosis.
Why this oneIt covers the endemic dimorphic fungi that fluconazole does not.
What limits itNegative inotropy, so it is contraindicated in heart failure. A strong CYP3A4 inhibitor; capsules need acid and food, the solution does not.
BOXED WARNING Negative inotropy/CHF — do not use for onychomycosis in ventricular dysfunction or CHF. Numerous CYP3A4-substrate drugs are contraindicated (risk of QT prolongation and torsade de pointes).
FDA dosing
Population
Start
Target
Max
Blastomycosis / Histoplasmosis
Adult
200 mg QD
200 mg QD
400 mg/day (doses >200 mg/day split BID)
Aspergillosis
Adult
200 mg/day
200-400 mg/day
400 mg/day
Life-threatening infection (loading)
Adult
200 mg TID (600 mg/day) x3 days
then usual maintenance
Onychomycosis — toenail
Adult
200 mg QD
200 mg QD x12 weeks
Onychomycosis — fingernail (pulse)
Adult
200 mg BID x1 week
200 mg BID x1 week per pulse
Renal Limited data; use with caution.
Hepatic Limited data; use with caution.
Fingernail onychomycosis: two 1-week pulses separated by a 3-week interval without drug.
Instructions
Take with a full meal to ensure maximal absorption
Swallow capsules whole
Capsules and oral solution are not interchangeable (only the solution is effective for oral/esophageal candidiasis)
Contraindications
Onychomycosis in patients with ventricular dysfunction or CHF / history of CHF
Onychomycosis in pregnant patients or women contemplating pregnancy
Cautions
Rare serious hepatotoxicity, including liver failure and death — monitor LFTs
Negative inotropic effect / risk of congestive heart failure
Many contraindicated CYP3A4-substrate co-medications (QT prolongation, torsade de pointes)
Adverse reactions
Nausea, vomiting, diarrhea
Rash, pruritus
Headache, dizziness
Edema, fatigue
Abnormal hepatic function
Hypertension, hypokalemia
Pregnancy Contraindicated for onychomycosis in pregnancy or women contemplating pregnancy.